Date
2021-12-01Journal
Frontiers in MicrobiologyPublisher
Frontiers Media S.A.Type
Article
Metadata
Show full item recordKeyword
functional curehuman immunodeficiency virus (HIV)
immunotherapy
latency
latency reversing agents (LRA)
Identifier to cite or link to this item
http://hdl.handle.net/10713/17556ae974a485f413a2113503eed53cd6c53
10.3389/fmicb.2021.797570
Scopus Count
Collections
Related articles
- Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
- Authors: Ruiz A, Blanch-Lombarte O, Jimenez-Moyano E, Ouchi D, Mothe B, Peña R, Galvez C, Genescà M, Martinez-Picado J, Goulder P, Barnard R, Howell B, Clotet B, Prado JG
- Issue date: 2018
- Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells.
- Authors: López-Huertas MR, Jiménez-Tormo L, Madrid-Elena N, Gutiérrez C, Vivancos MJ, Luna L, Moreno S
- Issue date: 2020 Dec
- Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.
- Authors: Hattori SI, Matsuda K, Tsuchiya K, Gatanaga H, Oka S, Yoshimura K, Mitsuya H, Maeda K
- Issue date: 2018
- Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency.
- Authors: Covino DA, Desimio MG, Doria M
- Issue date: 2021 Jun 22
- Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
- Authors: Liu B, Zou F, Lu L, Chen C, He D, Zhang X, Tang X, Liu C, Li L, Zhang H
- Issue date: 2016 Nov 1